Sign in

CIK 0001723128 · Large accelerated filer

Amneal Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
Phone
(908) 947-3120
Former names
Atlas Holdings, Inc.
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations · Regulation FD disclosure
  3. SCHEDULE 13D/A Stake Beneficial Ownership Report
  4. SCHEDULE 13D/A Stake Beneficial Ownership Report
  5. 4 Open-market sale Director sold 32,000 shares at $9.23 ($295,360)
  6. 144 Insider Sale of Securities
  7. 4 Open-market sale Executive Vice President sold 120,832 shares at an average $9.65 ($1,166,223)
  8. 4 Open-market sale Executive Vice President sold 279,244 shares at $9.38 ($2,619,309)
  9. 144 Insider Sale of Securities
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. 144 Insider Sale of Securities
  13. 4 Open-market sale Executive Vice President sold 71,694 shares at $9.29 ($666,037)
  14. 4 Open-market sale Executive Vice President & CFO sold 499,730 shares at an average $9.33 ($4,663,070)
  15. 144 Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. 4 Open-market sale Executive Vice President sold 50,000 shares at $9.04 ($452,000)
  18. 4 Open-market sale EVP, Chief Legal Officer sold 22,000 shares at $9.05 ($199,100)
  19. 4 Open-market sale Executive Vice President sold 33,436 shares at $9.05 ($302,596)
  20. 144 Insider Sale of Securities

Page 5 of 35 · 695 filings